Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose

Clinical Toxicology

Volumn 51, Issue 6, 2013, Pages 467-472

  Schmidt, Lars E ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acetaminophen; Adverse effects; Antidote; Ethnicity; Side effects

Indexed keywords

ACETYLCYSTEINE; PARACETAMOL;

ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHOSPASM; DRUG ERUPTION; DRUG OVERDOSE; DRUG REEXPOSURE; FEMALE; FLUSHING; HUMAN; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARACETAMOL OVERDOSE; PROPHYLAXIS; PRURITUS; RISK FACTOR; SIDE EFFECT; SKIN MANIFESTATION; URTICARIA; VOMITING;

ACETAMINOPHEN; ACETYLCYSTEINE; ADULT; ANALGESICS, NON-NARCOTIC; ANAPHYLAXIS; ANTIDOTES; DRUG HYPERSENSITIVITY; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; RECURRENCE; RISK FACTORS; YOUNG ADULT;

EID: 84879355435     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2013.799677     Document Type: Article

References (22)

1. Makin AJ, Wendon J, Williams R. Management of severe cases of paracetamol overdosage. Br J Hosp Med 1994;52:210-213.
2. Schmidt LE, Dalhoff K, Poulsen HE. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity. Hepatology 2002;35:876-882.
3. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979;2:1097-1100.
4. Clemmesen JO, Ott P, Dalhoff KP, Astrup LB, Tage-Jensen U, Poulsen HE. [Recommendations for treatment of paracetamol poisoning. Danish Medical Society, Study of the Liver]. Ugeskr L æ ger 1996;158:6892-6895.
5. Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol 2009;47:81-88.
6. Schmidt LE, Knudsen TT, Dalhoff K, Bendtsen F. Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury. Lancet 2002;360:1151.
7. Knudsen TT, Thorsen S, Jensen SA, Dalhoff K, Schmidt LE, Becker U, Bendtsen F. Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects. Gut 2005;54:515-521.
8. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous n-acetylcysteine. Ann Emerg Med 1998;31:710-715.
9. Bateman DN, Woodhouse KW, Rawlins MD. Adverse reactions to N-acetylcysteine. Hum Toxicol 1984;3:393-398.
10. Schmidt LE, Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001;51:87-91.
11. Lynch R M, Robertson R. A naphylactoid reactions to intravenous Nacetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004;12:10-15.
12. Waring WS, Stephen AF, Robinson OD, Dow MA, Pettie JM. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol (Phila) 2008;46:496-500.
13. Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol 2008;46:697-702.
14. Merl W, Koutsogiannis Z, Kerr D, Kelly AM. How safe is intravenous N-acetylcysteine for the treatment of paracetamol poisoning? Hong Kong J Emerg Med 2007;14:198-203.
15. Mant TG, Tempowski JH, Volans GN, Talbot JC. Adverse reactions to acetylcysteine and effects of overdose. BMJ 1984;289:217-219.
16. Reynard K, Riley A, Walker BE. Respiratory arrest after Nacetylcysteine for paracetamol overdose. Lancet 1992;340:675.
17. Ho SW, Beilin LJ. Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases. BMJ 1983;287:876-877.
18. Gheshlagi F, Izadi-Mood N, Amini R, Montazeri G. Prevalence of hypersensitivity reactions to intravenous N-acetylcysteine in acetaminophen poisoned patients. Clin Toxicol 2005;43:514-515.
19. Sanaei-Zadeh H, Taghaddosinejad F, Jalali N, Kariman H. Adverse effects of intravenous N-acetylcysteine: prospective study on 206 patients with paracetamol poisoning. Clin Drug Invest 2003;23:129-133.
20. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989;37:501-506.
21. Jepsen S, Hansen AB. The infl uence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest 1994;54:543-547.
22. Kerr F, Dawson A, Whyte I M, Buckley N, Murray L, Graudins A, et al. The Australasian Clinical Toxicology Investigators Collaboration randomized trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005;45:402-408.